Investors Research Corp Increases Stock Position in Danaher Corporation $DHR

Investors Research Corp raised its stake in shares of Danaher Corporation (NYSE:DHR) by 28,000.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,810 shares of the conglomerate’s stock after acquiring an additional 2,800 shares during the period. Investors Research Corp’s holdings in Danaher were worth $535,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Main Street Group LTD purchased a new position in shares of Danaher during the 1st quarter worth approximately $25,000. JPL Wealth Management LLC purchased a new stake in Danaher in the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC acquired a new position in Danaher during the second quarter worth $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in shares of Danaher during the fourth quarter worth $27,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently issued reports on DHR shares. Argus cut their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. Royal Bank Of Canada lifted their target price on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research note on Friday, April 17th. Morgan Stanley dropped their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Finally, JPMorgan Chase & Co. cut their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Trading Down 0.6%

NYSE:DHR opened at $206.23 on Thursday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market cap of $144.98 billion, a P/E ratio of 36.63, a P/E/G ratio of 2.58 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a 50-day simple moving average of $192.42 and a 200-day simple moving average of $193.36.

Danaher (NYSE:DHR) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the company earned $0.77 EPS. As a group, analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.